{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:24:14Z","timestamp":1790709854478,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hamilton Health Sciences New Investigator Award"},{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"crossref","award":["14-24"],"award-info":[{"award-number":["14-24"]}],"id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hamilton Health Sciences (CA) New Investigator Fund","award":["13342"],"award-info":[{"award-number":["13342"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-3080-y","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T03:32:49Z","timestamp":1545017569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevention of Infections in Cardiac Surgery study (PICS): study protocol for a pragmatic cluster-randomized factorial crossover pilot trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Rachel B.","family":"van Oostveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Romero-Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun Fu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Carignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. David","family":"Mazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-1613","authenticated-orcid":false,"given":"Dominik","family":"Mertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"3080_CR1","unstructured":"Adult Cardiac Surgery Database: Executive Summary. [Internet]. 2017. Available from: \n                    http:\/\/www.sts.org\/sites\/default\/files\/documents\/ACSD_2017Harvest2_ExecutiveSummary.pdf\n                    \n                  . Accessed 5 Dec 2018."},{"issue":"1","key":"3080_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.athoracsur.2005.06.034","volume":"81","author":"FH Edwards","year":"2006","unstructured":"Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR, Surgeons SoT. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg. 2006;81(1):397\u2013404.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"3080_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1067\/mtc.2000.110384","volume":"120","author":"R Saginur","year":"2000","unstructured":"Saginur R, Croteau D, Bergeron MG. Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. The ESPRIT Group. J Thorac Cardiovasc Surg. 2000;120(6):1120\u201330.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"3080_CR4","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/jac\/dkq080","volume":"65","author":"A Gupta","year":"2010","unstructured":"Gupta A, Hote MP, Choudhury M, Kapil A, Bisoi AK. Comparison of 48 h and 72 h of prophylactic antibiotic therapy in adult cardiac surgery: a randomized double blind controlled trial. J Antimicrob Chemother. 2010;65(5):1036\u201341.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"3080_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.athoracsur.2006.09.046","volume":"83","author":"R Engelman","year":"2007","unstructured":"Engelman R, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F, et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. Ann Thorac Surg. 2007;83(4):1569\u201376.","journal-title":"Ann Thorac Surg"},{"issue":"18","key":"3080_CR6","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/ajhp\/56.18.1839","volume":"56","author":"ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery","year":"1999","unstructured":"ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm. 1999;56(18):1839\u201388.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"3080_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","volume":"70","author":"DW Bratzler","year":"2013","unstructured":"Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195\u2013283.","journal-title":"Am J Health Syst Pharm"},{"key":"3080_CR8","unstructured":"Gilber DN. Sanford guide to antimicrobial therapy 2011 \/ editors: David N. Gilbert, M.D., Henry F. Chambers, M.D., George M. Eliopoulos, M.D., Michael S. Saag, M.D., Andrew T. Pavia, M.D.; 2011."},{"issue":"14","key":"3080_CR9","first-page":"e340","volume":"110","author":"KA Eagle","year":"2004","unstructured":"Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC\/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004;110(14):e340\u2013437.","journal-title":"Circulation"},{"issue":"4","key":"3080_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/sur.2009.023","volume":"11","author":"VG Alexiou","year":"2010","unstructured":"Alexiou VG, Ierodiakonou V, Peppas G, Falagas ME. Antimicrobial prophylaxis in surgery: an international survey. Surg Infect. 2010;11(4):343\u20138.","journal-title":"Surg Infect"},{"issue":"1","key":"3080_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/SLA.0b013e318214b7e4","volume":"254","author":"D Mertz","year":"2011","unstructured":"Mertz D, Johnstone J, Loeb M. Does duration of perioperative antibiotic prophylaxis matter in cardiac surgery? A systematic review and meta-analysis. Ann Surg. 2011;254(1):48\u201354.","journal-title":"Ann Surg"},{"issue":"3","key":"3080_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/jac\/dkr470","volume":"67","author":"A Lador","year":"2012","unstructured":"Lador A, Nasir H, Mansur N, Sharoni E, Biderman P, Leibovici L, et al. Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J Antimicrob Chemother. 2012;67(3):541\u201350.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3080_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/DCR.0000000000000633","volume":"59","author":"J Poeran","year":"2016","unstructured":"Poeran J, Wasserman I, Zubizarreta N, Mazumdar M. Characteristics of Antibiotic Prophylaxis and Risk of Surgical Site Infections in Open Colectomies. Dis Colon Rectum. 2016;59(8):733\u201342.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"3080_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/676436","volume":"35","author":"PP Hsiue","year":"2014","unstructured":"Hsiue PP, Gregson AL, Injean P, Vangala S, Brindis RG, Shemin RJ, et al. Variation in antibiotic prophylaxis selection for coronary artery bypass graft procedures in an era of increasing methicillin-resistant Staphylococcus aureus prevalence. Infect Control Hosp Epidemiol. 2014;35(6):737\u201340.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"3080_CR15","doi-asserted-by":"publisher","first-page":"e1002340","DOI":"10.1371\/journal.pmed.1002340","volume":"14","author":"W Branch-Elliman","year":"2017","unstructured":"Branch-Elliman W, Ripollone JE, O\u2019Brien WJ, Itani KMF, Schweizer ML, Perencevich E, et al. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study. PLoS Med. 2017;14(7):e1002340.","journal-title":"PLoS Med"},{"issue":"10","key":"3080_CR16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1086\/383318","volume":"38","author":"MK Bolon","year":"2004","unstructured":"Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis. 2004;38(10):1357\u201363.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3080_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1067\/mtc.2002.119698","volume":"123","author":"R Finkelstein","year":"2002","unstructured":"Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002;123(2):326\u201332.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"3080_CR18","first-page":"68","volume":"171","author":"EE Walsh","year":"2011","unstructured":"Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011;171(1):68\u201373.","journal-title":"Arch Intern Med"},{"issue":"2","key":"3080_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1128\/AAC.00495-07","volume":"52","author":"KW Garey","year":"2008","unstructured":"Garey KW, Lai D, Dao-Tran TK, Gentry LO, Hwang LY, Davis BR. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother. 2008;52(2):446\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"3080_CR20","doi-asserted-by":"publisher","first-page":"f2743","DOI":"10.1136\/bmj.f2743","volume":"346","author":"M Schweizer","year":"2013","unstructured":"Schweizer M, Perencevich E, McDanel J, Carson J, Formanek M, Hafner J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ. 2013;346:f2743.","journal-title":"BMJ"},{"key":"3080_CR21","unstructured":"Center for Disease Control and Prevention\/National Healthcare Safety Network (CDC\/NHSN): Surveillance Definitions for Specific Types of Infections. \n                    http:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/9pscSSIcurrent.pdf?agree=yes&next=Accept\n                    \n                  . Accessed 5 Dec 2018."},{"issue":"27","key":"3080_CR22","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1002\/sim.3383","volume":"27","author":"B Giraudeau","year":"2008","unstructured":"Giraudeau B, Ravaud P, Donner A. Sample size calculation for cluster randomized cross-over trials. Stat Med. 2008;27(27):5578\u201385.","journal-title":"Stat Med"},{"issue":"6","key":"3080_CR23","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.cjca.2013.01.020","volume":"29","author":"SJ Connolly","year":"2013","unstructured":"Connolly SJ, Philippon F, Longtin Y, Casanova A, Birnie DH, Exner DV, et al. Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the Prevention of Arrhythmia Device Infection Trial (PADIT). Can J Cardiol. 2013;29(6):652\u20138.","journal-title":"Can J Cardiol"},{"issue":"2","key":"3080_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/sim.2537","volume":"26","author":"RM Turner","year":"2007","unstructured":"Turner RM, White IR, Croudace T, Group PS. Analysis of cluster randomized cross-over trial data: a comparison of methods. Stat Med. 2007;26(2):274\u201389.","journal-title":"Stat Med"},{"issue":"22","key":"3080_CR25","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMms1604593","volume":"374","author":"LE Bothwell","year":"2016","unstructured":"Bothwell LE, Greene JA, Podolsky SH, Jones DS. Assessing the Gold Standard\u2013Lessons from the History of RCTs. N Engl J Med. 2016;374(22):2175\u201381.","journal-title":"N Engl J Med"},{"issue":"11","key":"3080_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jama.2016.11409","volume":"316","author":"HC Sox","year":"2016","unstructured":"Sox HC, Lewis RJ. Pragmatic Trials: Practical Answers to \u201cReal World\u201d Questions. JAMA. 2016;316(11):1205\u20136.","journal-title":"JAMA"},{"key":"3080_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1745-6215-10-61","volume":"10","author":"M Taljaard","year":"2009","unstructured":"Taljaard M, Weijer C, Grimshaw JM, Belle Brown J, Binik A, Boruch R, et al. Ethical and policy issues in cluster randomized trials: rationale and design of a mixed methods research study. Trials. 2009;10:61.","journal-title":"Trials"},{"issue":"4","key":"3080_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.amepre.2014.06.021","volume":"47","author":"LM Collins","year":"2014","unstructured":"Collins LM, Dziak JJ, Kugler KC, Trail JB. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med. 2014;47(4):498\u2013504.","journal-title":"Am J Prev Med"},{"issue":"2","key":"3080_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12160-010-9253-x","volume":"41","author":"LM Collins","year":"2011","unstructured":"Collins LM, Baker TB, Mermelstein RJ, Piper ME, Jorenby DE, Smith SS, et al. The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med. 2011;41(2):208\u201326.","journal-title":"Ann Behav Med"},{"key":"3080_CR30","unstructured":"Tri-Council Policy Statement. Ethical Conduct for Research Involving Humans. 2014. [Available from: \n                    http:\/\/www.pre.ethics.gc.ca\/pdf\/eng\/tcps2-2014\/TCPS_2_FINAL_Web.pdf\n                    \n                  ."},{"key":"3080_CR31","unstructured":"U.S. Department of Health & Human Services. Office for Human Research Protection. Attachment D: Informed Consent and Waiver of Consent 2013 [Available from: \n                    https:\/\/www.hhs.gov\/ohrp\/sachrp-committee\/recommendations\/2013-january-10-letter-attachment-d\/index.html\n                    \n                  . Accessed 5 Dec 2018."},{"issue":"25","key":"3080_CR32","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1161\/01.CIR.101.25.2916","volume":"101","author":"S Harbarth","year":"2000","unstructured":"Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101(25):2916\u201321.","journal-title":"Circulation"},{"issue":"5","key":"3080_CR33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/1740774515597688","volume":"12","author":"RE McKinney","year":"2015","unstructured":"McKinney RE, Beskow LM, Ford DE, Lantos JD, McCall J, Patrick-Lake B, et al. Use of altered informed consent in pragmatic clinical research. Clin Trials. 2015;12(5):494\u2013502.","journal-title":"Clin Trials"}],"updated-by":[{"DOI":"10.1186\/s13063-019-3771-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-3080-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T19:18:33Z","timestamp":1576523913000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-3080-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13063-019-3771-z","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"4 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], we have been notified of a few mistakes in the \u201cSample size calculations\u201d section, second paragraph.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was granted by the principal investigator\u2019s research ethics board for Hamilton Health Sciences, Hamilton, ON (REB#15\u2013129) and was subsequently approved by the local research ethic boards at the two other study sites (Sherbrooke University, Sherbrooke, QC, and St. Michael\u2019s Hospital, Toronto, ON).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"688"}}